Long-term linear growth of children with severe steroid-responsive nephrotic syndrome.

Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children. Clin J Am Soc Nephrol (2009) 2.84

Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J Med Genet (2005) 1.69

Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr Nephrol (2009) 1.32

Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. J Am Soc Nephrol (2014) 1.20

Late consequences of chronic pediatric illness. Psychiatr Clin North Am (2007) 1.07

Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome. Pediatr Nephrol (2008) 0.85

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. Clin Exp Nephrol (2015) 0.85

Impact of rituximab on height and weight in children with refractory steroid-dependent nephrotic syndrome. Pediatr Nephrol (2014) 0.81

The Effect of Long-term Steroid Therapy on Linear Growth of Nephrotic Children. Iran J Pediatr (2011) 0.77

The non-immunosuppressive management of childhood nephrotic syndrome. Pediatr Nephrol (2015) 0.77

Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome. Eur J Pediatr (2015) 0.77

Growth in boys with idiopathic nephrotic syndrome on long-term cyclosporin and steroid treatment. Pediatr Nephrol (2009) 0.76

Minimal Change Disease. Clin J Am Soc Nephrol (2016) 0.75

Malnutrition and catch-up growth during childhood and puberty. World Rev Nutr Diet (2014) 0.75

Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child (1976) 12.33

Normal growth and techniques of growth assessment. Clin Endocrinol Metab (1986) 3.13

Long-term outcome for children with minimal-change nephrotic syndrome. Lancet (1985) 1.52

Italian cross-sectional growth charts for height, weight and BMI (6-20 y). Eur J Clin Nutr (2002) 1.46

Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med (2000) 1.28

Long-term outcome of primary nephrotic syndrome. Arch Dis Child (1982) 1.28

Growth and endocrine function in steroid sensitive nephrotic syndrome. Arch Dis Child (1988) 0.95

Height attainment in children with steroid-responsive nephrotic syndrome. Lancet (1985) 0.93

Effect of long-term corticosteroids and corticotrophin on the growth of children. Lancet (1966) 0.93

Effect of prednisone on growth and bone mineral content in childhood glomerular disease. Am J Dis Child (1978) 0.91

Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity, and infection rate. Clin Pediatr (Phila) (1988) 0.89

Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis. Arch Dis Child (1968) 0.87

Body growth of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol (1999) 0.86

Linear growth of children with nephrotic syndrome: effect of alkylating agents. Pediatrics (1989) 0.85

Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation. J Pediatr (1992) 0.84

Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation (1996) 0.83

Normal growth of nephrotic children during long-term alternate-day prednisone therapy. Acta Paediatr Scand (1986) 0.82

Normal growth of prepubertal nephrotic children during long-term treatment with repeated courses of prednisone. Acta Paediatr (1998) 0.79

Analysing curves using kernel estimators. Pediatr Nephrol (1991) 0.77

Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth. Am J Kidney Dis (1987) 0.77

The gene mutated in juvenile nephronophthisis type 4 encodes a novel protein that interacts with nephrocystin. Nat Genet (2002) 2.41

Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. Emerg Infect Dis (2003) 2.12

X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study. J Am Soc Nephrol (2003) 2.12

Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol (2002) 1.73

Blood pressure in the long-term follow-up of children with hemolytic uremic syndrome. Pediatr Nephrol (2004) 1.39

Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol (2005) 1.36

Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol (2003) 1.33

Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis (2003) 1.13

Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome. Semin Thromb Hemost (2006) 1.09

Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor-1 beta gene: description of a new family with associated liver involvement. Am J Kidney Dis (2002) 0.99

Chronic peritoneal dialysis catheters in children: a fifteen-year experience of the Italian Registry of Pediatric Chronic Peritoneal Dialysis. Perit Dial Int (2004) 0.98

Epidermal basement membrane alpha 5(IV) expression in females with Alport syndrome and severity of renal disease. Kidney Int (2003) 0.93

Mutational spectrum of the CTNS gene in Italy. Eur J Hum Genet (2003) 0.93

Impaired activity of the gamma-glutamyl cycle in nephropathic cystinosis fibroblasts. Pediatr Res (2006) 0.91

Shiga toxins present in the gut and in the polymorphonuclear leukocytes circulating in the blood of children with hemolytic-uremic syndrome. J Clin Microbiol (2006) 0.89

Total peripheral vascular resistance in pediatric renal transplant patients. Kidney Int (2002) 0.86

Role of non-polio enterovirus infection in pediatric hemolytic uremic syndrome. Pediatr Nephrol (2002) 0.85

Confirmation of the ATP6B1 gene as responsible for distal renal tubular acidosis. Pediatr Nephrol (2002) 0.85

Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome. Cytometry B Clin Cytom (2004) 0.85

Confocal microscopy of the skin in the diagnosis of X-linked Alport syndrome. J Invest Dermatol (2003) 0.85

One-year angiotensin-converting enzyme inhibition plus mycophenolate mofetil immunosuppression in the course of early IgA nephropathy: a multicenter, randomised, controlled study. J Nephrol (2005) 0.83

Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome. Pediatr Nephrol (2004) 0.82

Risk factors for poor renal prognosis in children with hemolytic uremic syndrome. Pediatr Nephrol (2003) 0.81

"Bartter-like" phenotype in Kearns-Sayre syndrome. Pediatr Nephrol (2005) 0.81

Does growth hormone treatment affect the risk of post-transplant renal cancer? Pediatr Nephrol (2002) 0.79

Parathyroid hormone levels in pubertal uremic adolescents treated with growth hormone. Pediatr Nephrol (2003) 0.77

Cystinuria. Acta Paediatr Suppl (2006) 0.76

Long-term renal function in heart transplant children on cyclosporine treatment. Pediatr Nephrol (2006) 0.76

Differential diagnosis between X-linked Alport syndrome and thin basement membrane nephropathy. Kidney Int (2004) 0.75

Renal mass dosing and graft function in children transplanted from pediatric donors. Pediatr Nephrol (2002) 0.75